Miri Halperin Wernli in

Miri Halperin Wernli

Login to view DISC.
Chairman of the Board of Directors ReConnect-Labs Switzerland at Reconnect Labs
📍 Zug, Zug, Switzerland

Miri Halperin Wernli is a strategic healthcare executive with over 30 years of leadership in the life sciences, biotech, and pharmaceutical industries at companies like Roche, Merck, and Actelion. A scientist and entrepreneur with a Doctorate from the University of Geneva and an Executive MBA from Stanford, she has deep expertise in drug development and corporate strategy.

She has a keen intellectual curiosity in the convergence of technology, nature, and human experience. Her interests range from the complexities of animal behavior and the natural world to the philosophical implications of artificial intelligence and the intersection of nutrition with biotechnology for healthy aging.

Her board directorships showcase a unique blend of interests, spanning from precision neuropsychiatry and humanitarian aid technology to wellness retreats that incorporate plant-assisted experiences.

Read the full overview →
Experience
24 Years
Current Role
Chairman of the Board of Directors ReConnect-Labs Switzerland
Job Level
Mid-senior
Location
Zug, Zug, Switzerland
Personality Overview

How Miri shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Miri cares about

Neuroscience & Psychiatry
As Chairman of Reconnect Labs and former President of MindMed, she is a leader in developing novel treatments for mental health and neurological disorders.
Biotech & Longevity
She follows the convergence of biotechnology and nutrition, particularly how functional foods can influence healthy aging by targeting biological mechanisms like senescent cells.
+5 more topics Login to view topics
Career

Work history

1-2026
Chairman of the Board of Directors ReConnect-Labs Switzerland
Reconnect Labs
10-2025
Board Director AIDONIC Switzerland
AIDONIC
8-2023
Board Director Dimensions Canada
Dimensions Retreats
8-2020 - 3-2025
Executive President MindMed
Executive President of Mind Medicine (MindMed) Inc. (Nasdaq: MNMD) www.mindmed.co
8-2020 - 3-2021
Board Director
Creso Pharma
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1974 - 1984
Dr.
University of Geneva
1997 - 1998
Executive MBA
Stanford University Graduate School of Business
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Miri. Free, 10 seconds.